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a  b  s  t  r  a  c  t
INTRODUCTION:  Takayasu’s  arteritis  (TA)  is  a rare  disease  that  mainly  affects  large  arteries.  Approxi-
mately  20%  of TA  patients  will  require  surgical  intervention  secondary  to arterial  complications  such  as
intermittent  claudication,  persistent  hypertension  refractory  to  treatment,  and heart  failure.
PRESENTATION  OF  CASE:  The  case  of  a  22-year-old  female  with  TA of  ﬁve  years  of  evolution  is presented.
The  patient  deteriorated  clinically  after  ﬁve  years  of corticosteroid  and  immunosuppressant  management
requiring  surgical  intervention  with an  axillobifemoral  bypass  for a total  abdominal  occlusion.  Onset,  pre-
surgical  and post-surgical  Doppler  ultrasonography  as well  as  abdominal  angiotomographies  document
and  corroborate  the  patient’s  clinical  and  hemodynamic  improvement.
DISCUSSION:  Very  limited  literature  exists  regarding  surgical  interventions  for  TA patients.  While  most
reported  cases  present  an endovascular  surgical  management.  Open  surgical  procedures  have  lower  rates
of restenosis  than  endovascular  management.  Although  endovascular  management  is  less  invasive than
extra-anatomical  axillobifemoral  bypass,  the  patient was  not  a candidate  for endovascular  stent  graft
placement  due  to the  increased  risk  for  vascular  injury  and subsequent  perforation.  Approximately  a
ﬁfth  of TA  patients  are  candidates  for surgical  intervention  over time.
CONCLUSION:  Vascular  surgery  in  TA  cases  becomes  an  option  when  the  patient  does  not  improve
clinically  after  administration  of  medical  treatment.  Although  endovascular  management  has  fewer
complications,  the  rate  of restenosis  is higher.  Patients  at risk  of  restenosis  and who  have increased
perioperative  vascular  risk  can  beneﬁt  from  open  surgical  procedures.  Surgical  management  should  be
tailored  to  the patient’s  needs.
©  2019  Published  by  Elsevier  Ltd on  behalf  of  IJS  Publishing  Group  Ltd.  This  is  an  open  access  article. Introduction
Takayasu’s arteritis (TA) is a chronic, inﬂammatory, granulo-
atous, idiopathic disease that affects arteries such as the aorta
nd its ramiﬁcations, as well as the pulmonary artery [1,2]. Arte-
ial vasculitis in TA is characterized by both dilation and stenosis.
istopathological ﬁndings include a panarteritis which shows
nﬂammation around the vasorum vessel as well as the adventi-
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tia, with a perivascular mononuclear inﬁltrate, composed mainly of
CD4+/CD8+ lymphocytes, plasma cells, and macrophages [1]. TA is
a rare disease and it is more prevalent in Central and South Amer-
ica, Africa, India, and the Far East [3]. TA has a prevalence in the
Japanese population of 0.004% and a yearly incidence of between
0.7–4.7 cases per million [3–6].
The clinical presentation associated with TA is unspeciﬁc. Symp-
toms can range from constitutional symptoms (e.g. fatigue, fever,
and weight loss) to claudication, cephalalgia, syncope, angina pec-
toris, and abdominal pain which are associated to vascular territory
affected by the arteritis [6,7]. Although there is no imaging or lab-
oratory gold standards with adequate sensitivity of speciﬁcity for
TA, the American College of Rheumatology and Ishikawa diagnostic
n open access article under the CC BY license (http://creativecommons.org/licenses/
ey.com by Elsevier on August 20, 2019.
. Elsevier Inc. All rights reserved.































































Laboratory test results upon admission the Emergency Department.
Full Blood Count
Hemoglobin at admission 14.5 g/dL
Hematocrit 44.5%
Erythrocyte count 5300 L
Platelet count 296,000L
Mean corpuscular volume 85fL










Urea nitrogen 0.60 mg/dL
Blood urea nitrogen 12.9 mg/dL




Aspartate transaminase 9 U/L
Alanine transaminase 12 U/L
Lactate dehydrogenase 10 U/L
Albumin 3.5 mg/dL
Alkaline phosphatase 66.8 U/L
Gamma-glutamyl transpeptidase 10 U/L
Blood Coagulation
Prothrombine time 18 Sec
Partial thromboplastin time 40 Sec









Complementary laboratory test results.
Follow-up
Immunological assay
Anti-double-stranded deoxyribonucleic acid 0.9 UI/mL
Anti-cardiolipin IgG 1.0 UI/mL
Anti-cardiolipin IgM antibody 3.0 UI/mL
Erythrocyte sedimentation rate 15 mm/h
C-reactive protein 3.80 mg/dL
Viral assay
Hepatitis B virus Negative
Hepatitis C virus Negative
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riteria are the most widely adopted criteria [7–9]. These criteria
ncorporate age at disease onset, muscular and arterial tender-
ess, claudication, pulse characteristics, blood pressure differences,
ndings related to arterial auscultation, arteriogram ﬁndings, and
chocardiographic alterations [8,9]. While 20% of TA patients have
 self-limited disease progression, up to 20% will require surgical
ntervention secondary to arterial complications [7]. Intermittent
laudication, persistent hypertension refractory to treatment, and
eart failure are among the most common indications for surgical
ntervention in TA [10].
We present the case report in line with the SCARE criteria [11]
f a patient with TA treated in a university hospital, who after
ve years of corticosteroid and immunosuppressant management
eteriorated clinically requiring surgical intervention with an axil-
obifemoral bypass for a total abdominal occlusion. Very limited
iterature exists regarding surgical interventions for TA patients.
his case contributes to the existing literature with a successful
urgical case that documented through various imaging modalities
 patient for over ﬁve years.
. Case presentation
A 22-year-old female arrived at the Emergency Department
resenting claudication when walking less than 300 m as well as
ncreased paresthesia and dysesthesia in both pelvic limbs. The
laudication, paresthesia, and dysesthesia began ﬁve years earlier.
t the time of onset, the claudication was bilateral after walk-
ng approximately 1500 m with improvement after rest, while
he paresthesia and dysesthesia were bilateral and involved all
our extremities. At that time, the patient was diagnosed with
akayasu’s arteritis (TA) by the Rheumatology department from
his institution based on immunological proﬁle (i.e. rheuma-
oid factor, antinuclear antibodies, anticardiolipin antibodies, and
ntineutrophil cytoplasmic antibodies (ANCA), the American Col-
ege of Rheumatology and Ishikawa criteria. [8,9] Six months prior
o the patient’s visit to this hospital, claudication progressed (i.e.
eduction in the distance able to walk to 500 m,  increasing pares-
hesia and dysesthesia frequency). The patient had no relevant
amily and personal non-pathological history to her current condi-
ion. The patient denied the use of controlled substances, allergies,
ast blood transfusions, traveling to regions with endemic diseases
ithin the last three months, tattoos and body piercings.
Upon initial physical examination, we found a patient recum-
ent with freely chosen body position, Glasgow coma score of 15,
ithout focal neurologic deﬁcits nor meningeal sings, aware of
is environment, with reference to place, time, and people. The
atient’s integumentary system was hydrated and without alter-
tions, while the head and neck exploration had no alterations.
pon inspection, palpation, and percussion the cardio-respiratory
ystem and abdomen had no abnormal ﬁndings. Precordial aus-
ultation revealed tachycardia, but no aggregate phenomena.
bdominal auscultation revealed a systolic murmur grade III/IV at
he mesogastrium. Right upper limb exploration revealed normal
xillar, humeral, and radial pulses (i.e. presence of rhythmic, with
ormal intensity +++/+++, normal amplitude, and having a syn-
hronous frequency with heart rate). The right ulnar artery pulse
as absent. Upon left upper limb exploration, palpation showed
he presence of normal axillar and humeral pulses; while radial and
lnar pulses were absent. Lower limb exploration showed absence
f bilateral femoral, popliteal and posterior tibial pulses. The skin
resented cyanotic appearance, especially of the toes of both feet.
pon palpation, reduced skin temperature was noticed and absence
f edema. Upon admission, the patient had the following vital signs:
lood pressure 100/70 mmHg  in the right arm, 80/60 mmHg  in the
eft arm, blood pressure in the right leg and the left leg were not
Downloaded for Anonymous User (n/a) at University of Groningen from Clini
For personal use only. No other uses without permission. Copyright ©2PEN  ACCESS
f Surgery Case Reports 61 (2019) 147–152
detectable; heart rate 85bpm; respiratory rate 17 rpm; tempera-
ture 36 ◦C; weight 65 kg; height 167 cm;  body mass index23.3 kg/m
[2]. Laboratory results at admission are presented in Table 1 and the
follow-up laboratory results in Table 2.Ketones, glucose, and nitrite Negative
Leukocytes 2 per high power ﬁeld
Erythrocytes 3 per high power ﬁeld
Bacteria Absent
calKey.com by Elsevier on August 20, 2019.
019. Elsevier Inc. All rights reserved.
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F at the time of diagnosis. A) Coronal reconstruction showing emergence of aortic artery
2 sis of approximately 64 mm (marked by arrow). B) Coronal 3-D reconstruction. Multiple
































Blood ﬂow velocities at time of diagnosis.
Anatomical region Velocity (cm/sec)
Upper limbs Right Left
Axillary artery 77 87
Proximal segment brachial artery 76 82
Middle segment brachial artery 70 75
Distal segment brachial artery 62 51
Proximal segment radial artery 45 37
Distal segment radial artery 31 35
Proximal segment ulnar artery 43 33
Distal segment ulnar artery 42 33
Abdominal aorta
Suprarenal segment 160
Infrarrenal proximal segment 253
Infrarrenal distal segment 288
External iliac artery 230 153
Lower limbs Right Left
Common femoral artery 36 25
Proximal segment superﬁcial femoral artery 21 16
Middle segment superﬁcial femoral artery 17 15
Distal segment superﬁcial femoral artery 13 11
Popliteal artery 12 11
Proximal segment anterior tibial artery 12 19
Middle segment anterior tibial artery 12 6
Distal segment anterior tibial artery 7 7
Proximal segment posterior tibial artery 10 10
Middle segment posterior tibial artery 8 6
Distal segment posterior tibial artery 10 8
Proximal segment ﬁbular artery 7 13ig. 1. Abdominal angiotomography showing aortic and multiple vessel stenoses 
7  mm from the renal arteries with stenosis superior to 50%. The length of the steno
ollateral arteries are present with a prominent and dilated arc of Riolan with vascu
. Clinical history
During initial symptom onset (i.e. ﬁve years prior to this hospi-
al admission) the patient had absent left upper limb distal pulses
i.e. radial and ulnar pulse). The right upper limb pulses (i.e. axil-
ar, humeral, ulnar, and radial) and left axillar and humeral pulses
ad were present, rhythmic, with normal intensity (i.e. +++/+++),
nd having a synchronous frequency with heart rate. Lower limb
xploration showed normal left limb pulses (i.e. femoral, popliteal,
osterior tibial and dorsal pedis) and decreased right femoral
i.e. present, decreased frequency and amplitude, and intensity
+/+++), right popliteal (i.e. present, rhythmic, intensity +/+++, and
ecreased amplitude) pulses and absent right limb distal pulses (i.e.
osterior tibial and dorsalis pedis).
During the initial onset, the patient underwent pulsed-wave
oppler ultrasonography (i.e. spectral) of the lower limbs. The
eported arterial blood ﬂow velocities of the common femoral
rtery, right superﬁcial femoral artery, left superﬁcial femoral
rtery, right popliteal artery, and left popliteal artery were dimin-
shed and are found in Table 3. The waveform was monophasic with
 dampened pattern compatible with a bilateral femoropopliteal
nsufﬁciency. Doppler ultrasonography of the abdominal aorta had
 50% diameter reduction below the renal arteries level. An abdom-
nal angiotomography reported aortic and multiple vessel stenoses
Fig. 1a).
Initial treatment was prednisone 50 mg  orally (per os, PO) every
quaque, q) 24 h, methotrexate 20 mg  PO q7days, and folic acid
0 mg  PO q7d. After six months and clinical improvement the pred-
isone dose was adjusted (i.e. prednisone 7.5 mg  PO q24 h) for two
ears. After withstanding a bout of purpuric pigmented dermato-
is the dose of prednisone was adjusted to 15 mg  PO q7d and topic
lioquinol and clindamycin for two weeks was administered.. Clinical evolution and surgical management
Transesophageal echocardiography (TEE) was  performed to
ssess presence aortic root abnormalities. The TEE reported a left
Downloaded for Anonymous User (n/a) at University of Groningen from ClinicalK
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ventricular ejection fraction of 66%, without the presence of intra-
cavitary thrombi. Supra-aortic Doppler ultrasonography revealed a
tardus-parvus waveform at the right vertebral artery suggestive of
stenosis at the right subclavian artery. The right common carotid
artery showed a hyperechoic image (i.e. 22 mm x 3 mm)  compati-
ble with an atheroma, without reduction of blood ﬂow velocity (i.e.
20 cm/sec and 30% stenosis). An abdominal angiotomography was
performed, reporting irregular wall thickening of the abdominal
aorta with a 5.8 cm extension (i.e. originating below the emergence
ey.com by Elsevier on August 20, 2019.
. Elsevier Inc. All rights reserved.
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Post-operative blood ﬂow velocities of major lower extremity arteries.
Anatomical region Velocity (cm/sec)
Lower limbs Right Left
Common femoral artery 44 44
Proximal segment superﬁcial femoral artery 27 29
Middle segment superﬁcial femoral artery 23 25
Distal segment superﬁcial femoral artery 18 22
Popliteal artery 16 20
Proximal segment anterior tibial artery 14 19
Middle segment anterior tibial artery 10 13
Distal segment anterior tibial artery 9 11
Proximal segment posterior tibial artery 16 12
Middle segment posterior tibial artery 14 10
Distal segment posterior tibial artery 13 9
Proximal segment ﬁbular artery 10 12Fig. 2. Post-surgical abdominal angiotomography showing a permeable axi
f the superior mesenteric artery and extending to the bifurcation
f the iliac arteries) and both iliac arteries presented a total occlu-
ion of approximately 4.3 cm (Fig. 1a and b). However, the arc of
iolan was permeable in its entirety (Fig. 1b).
Extra-anatomical revascularization was performed, with the
lacement of an 8 mm axillobifemoral poly-tetraﬂuoroethylene
PTFE)-based prosthetic graft. Sterile technique was procured at
ll times. The vascular access for the prosthetic graft placement
as the left infra-clavicular region, with a right femoral end-to-
nd anastomosis. The graft was tunneled subcutaneously along
he midaxillary line to prevent graft entanglement due to torso
exion. Upper and lower limb pulses were present after arterial
nclamping. Minimal hemorrhage (i.e. less than 400cc) and no
omplications were reported during and after surgery. Seventy-
wo hours after the procedure the patient was discharged from the
ospital with clinical improvement.
Two weeks after the surgical procedure the patient was  clini-
ally evaluated. The patient reported symptom improvement (i.e.
aresthesia, dysesthesia, and claudication). Upon physical exami-
ation, both inferior limbs had femoral, popliteal, posterior tibial,
nd dorsal pedis pulses present, symmetric, rhythmic, with low
mplitude, intensity ++/+++, and in synchrony with the heart rate.
he skin showed no distal cyanosis, temperature changes or edema.
he patient underwent pulsed-wave Doppler ultrasonography of
he lower limbs with adequate blood ﬂow. A post-surgical abdom-
nal angiotomography was performed which showed a permeable
xillobifemoral prosthetic graft (Fig. 2). The postoperative blood
ow velocities are reported in Table 4. The patient was managed
ith prednisone 10 mg  PO q24 h and rivaroxaban 20 mg  PO q24 h,
ithout reporting adverse effects (i.e. 3 months post-surgery).
. DiscussionWe  present the case report of a patient with TA, who  after
ve years of corticosteroid and immunosuppressant management
eteriorated clinically requiring surgical intervention with an axil-
Downloaded for Anonymous User (n/a) at University of Groningen from Clini
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lobifemoral bypass for a total abdominal occlusion. Very limited
literature exists regarding surgical interventions for TA patients.
Most reported cases present endovascular surgical management.
Although endovascular management is less invasive than extra-
anatomical axillofemoral bypass, the patient was not a candidate
for endovascular stent graft placement due to the increased risk for
vascular injury and subsequent perforation. Considering the age of
the patient, 22-years, open aortic repair is the preferred option and
considering that axillobifemoral bypass surgery has the same long-
term patency regardless of age, a strong argument can be made that
this procedure should be avoided in younger populations. However,
due to the patient’s overall ﬁtness and after a preoperative assess-
ment from the Internal Medicine and Anesthesiology departments
a consensus was  reached between these two departments and the
Surgery department (i.e. the position of the surgical team was to
perform an aortic repair) that open aortic repair was not a suit-
able procedure due to the high intraoperative risk. The left axillary
artery was  chosen as inﬂow vessel over the right even after having
lower systolic blood pressure because the right subclavian artery
calKey.com by Elsevier on August 20, 2019.
019. Elsevier Inc. All rights reserved.






























































O. Jiménez-Zarazúa et al. / International Jou
ad Doppler ultrasonography ﬁndings suggestive of stenosis and
o distal aortic arch or left subclavian artery stenosis was detected
hrough the same procedure. This case contributes to the existing
iterature with a successful surgical case that documented through
arious imaging modalities a patient for over ﬁve years.
Vascular surgery in TA cases becomes an option when the
atient does not improve clinically after administration of medical
reatment. Corticosteroids are the mainstay of the therapeu-
ic management for TA, while immunosuppressant drugs (e.g.
zathioprine, methotrexate, cyclophosphamide, mycophenolate,
acrolimus, and leﬂunomide) are widely used as maintenance ther-
py [7]. Furthermore, biopharmaceuticals such as inﬂiximab and
tanercept are therapeutic options for selected cases [12,13]. Over
ime about a ﬁfth of the patients require surgical management
nd endovascular alternatives are preferred due to their less inva-
iveness. Percutaneous transluminal angioplasty and stent-graft
lacement are among the endovascular options available for TA,
hile surgical revascularization can be performed via surgical
ypass grafting, patch angioplasty for short-segment lesions and
ndarterectomy [14].
Extra-anatomical axillofemoral bypass surgery is a procedure
hat is performed in other pathologies such as aortic coarctation,
ortic aneurysm, aortoiliac occlusive disease, and TA. In 2004,
 case similar to the one presented by our group successfully
erformed an axillobifemoral bypass for a total abdominal aorta
cclusion [15]. Another example in the literature of successful
xillobifemoral bypass in TA to treat both atypical coarctation
nd brachiocephalic involvement [16]. The case presented can be
ssessed as a successful procedure based on post-surgical clinical
nd imaging hemodynamic improvement. Although no intraoper-
tive or perioperative complications were reported, these include
rachial plexus injury, axillary pullout syndrome, graft thrombosis,
elayed pseudoaneurysm of the graft, and graft infection. Clinically
he patient had detectable bilateral lower extremity pulses, had
educed paresthesia and dysesthesia, as well as not reporting clau-
ication during the three months after the surgical procedure. The
atient also had increased post-surgical vascular velocities in both
ower extremities, as well as an abdominal angiotomography with
 permeable axillobifemoral prosthetic graft.
. Limitations
Disease activity is a key factor that inﬂuences the decision to
roceed with revascularization. Both endovascular and surgical
evascularization should be avoided during acute TA disease activ-
ty as reocclusion and complications during the surgical procedure
17]. Disease activity is deﬁned by a combination of clinical signs
nd symptoms, laboratory assessment and vascular imaging [7].
oth acute phase reactants, erythrocyte sedimentation rate, and
-reactive protein are useful to monitor TA disease activity; how-
ver, on their own, these serological tests prove to be insufﬁcient
o asses TA disease activity [18]. Although the patient did not
ave imaging or laboratory indicators for acute TA disease activ-
ty, active vasculitis cannot be completely dismissed. Among the
wo surgical approaches, open surgical intervention has a lower
isk for restenosis than endovascular procedures as a late com-
lication (i.e. 10-year follow-up), with a rate of restenosis of 37%
ersus 62%, respectively [6,19–21]. Another limitation of the study
s the exclusion of other possible differential diagnoses. Middle aor-
ic syndrome (MAS) could not be completely dismissed due to the
atient’s young age. MAS  can be due to congenital syndromes neu-
oﬁbromatosis, mucopolysaccharidoses, Williams syndrome and,
lagille syndrome [22]. No genetic tests were performed on our
atient, hence a genetic cause could be the etiology behind the
ortic stenosis.
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7. Conclusion
One in ﬁve TA patients over time become refractory to med-
ical treatment. Vascular surgery is an option in these refractory
cases. Two  types of surgical interventions are available endovas-
cular and open surgical procedures. Among the endovascular
options available for TA are percutaneous transluminal angioplasty
and stent-graft placement, while surgical revascularization can
be performed via surgical bypass grafting, patch angioplasty for
short-segment lesions and endarterectomy. Although endovascu-
lar management has fewer complications, the rate of restenosis is
higher. Patients at risk of restenosis and who  have increased peri-
operative vascular can beneﬁt from open surgical procedures. The
surgical management should be tailored to the patient’s needs, tak-
ing into account the extension of the lesion, available resources, and
the treating surgeon’s experience.
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